82 related articles for article (PubMed ID: 32319567)
1. Lewis antigen‑negative pancreatic cancer: An aggressive subgroup.
Liu C; Deng S; Jin K; Gong Y; Cheng H; Fan Z; Qian Y; Huang Q; Ni Q; Luo G; Yu X
Int J Oncol; 2020 Apr; 56(4):900-908. PubMed ID: 32319567
[TBL] [Abstract][Full Text] [Related]
2. Pathobiological implications of MUC16 expression in pancreatic cancer.
Haridas D; Chakraborty S; Ponnusamy MP; Lakshmanan I; Rachagani S; Cruz E; Kumar S; Das S; Lele SM; Anderson JM; Wittel UA; Hollingsworth MA; Batra SK
PLoS One; 2011; 6(10):e26839. PubMed ID: 22066010
[TBL] [Abstract][Full Text] [Related]
3. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter.
Luo G; Jin K; Deng S; Cheng H; Fan Z; Gong Y; Qian Y; Huang Q; Ni Q; Liu C; Yu X
Biochim Biophys Acta Rev Cancer; 2021 Apr; 1875(2):188409. PubMed ID: 32827580
[TBL] [Abstract][Full Text] [Related]
4. Clinical implication of serum CA125 for the prediction of malignancy in mucinous cystic neoplasms of the pancreas.
Deng S; Fan Z; Gong Y; Cheng H; Jin K; Qian Y; Xiao Z; Liu Y; Wang R; Zheng Y; Ni Q; Yu X; Liu C; Luo G
Exp Ther Med; 2020 Dec; 20(6):158. PubMed ID: 33093896
[TBL] [Abstract][Full Text] [Related]
5. High pre-operative fasting blood glucose levels predict a poor prognosis in patients with pancreatic neuroendocrine tumour.
Gong Y; Fan Z; Zhang P; Qian Y; Huang Q; Deng S; Luo G; Cheng H; Jin K; Ni Q; Yu X; Liu C
Endocrine; 2021 Feb; 71(2):494-501. PubMed ID: 32862321
[TBL] [Abstract][Full Text] [Related]
6. Absolute Counts of Peripheral Lymphocyte Subsets Correlate with the Progression-Free Survival and Metastatic Status of Pancreatic Neuroendocrine Tumour Patients.
Gong Y; Fan Z; Luo G; Huang Q; Qian Y; Cheng H; Jin K; Ni Q; Yu X; Liu C
Cancer Manag Res; 2020; 12():6727-6737. PubMed ID: 32848455
[TBL] [Abstract][Full Text] [Related]
7. Prognosis of distal pancreatic cancers controlled by stage.
Luo G; Jin K; Cheng H; Guo M; Gong Y; Fan Z; Yang C; Huang Q; Ni Q; Liu C; Yu X
Exp Ther Med; 2020 Aug; 20(2):1091-1097. PubMed ID: 32742348
[TBL] [Abstract][Full Text] [Related]
8. Diabetes Is Associated With the Metastasis of Pancreatic Neuroendocrine Tumors.
Fan Z; Gong Y; Huang Q; Yang C; Cheng H; Jin K; Fan K; Ni Q; Yu X; Luo G; Liu C
Pancreas; 2020 Jul; 49(6):751-756. PubMed ID: 32541629
[TBL] [Abstract][Full Text] [Related]
9. Oncogenic function of TRIM2 in pancreatic cancer by activating ROS-related NRF2/ITGB7/FAK axis.
Sun Q; Ye Z; Qin Y; Fan G; Ji S; Zhuo Q; Xu W; Liu W; Hu Q; Liu M; Zhang Z; Xu X; Yu X
Oncogene; 2020 Oct; 39(42):6572-6588. PubMed ID: 32929153
[TBL] [Abstract][Full Text] [Related]
10. Pancreatic cancer.
Mizrahi JD; Surana R; Valle JW; Shroff RT
Lancet; 2020 Jun; 395(10242):2008-2020. PubMed ID: 32593337
[TBL] [Abstract][Full Text] [Related]
11. Glucose deprivation-induced aberrant FUT1-mediated fucosylation drives cancer stemness in hepatocellular carcinoma.
Loong JH; Wong TL; Tong M; Sharma R; Zhou L; Ng KY; Yu HJ; Li CH; Man K; Lo CM; Guan XY; Lee TK; Yun JP; Ma SK
J Clin Invest; 2021 Jun; 131(11):. PubMed ID: 33878034
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic cancer treatment: better, but a long way to go.
Torphy RJ; Fujiwara Y; Schulick RD
Surg Today; 2020 Oct; 50(10):1117-1125. PubMed ID: 32474642
[TBL] [Abstract][Full Text] [Related]
13. Lewis Antigen Phenotype and Survival of Patients With Pancreatic Cancer.
Kwon S; Kim S; Giovannucci EL; Hidalgo M; Markey MK; Bovik AC; Kwon MJ; Kim KJ; Im H; Park JY; Bang S; Park SW; Song SY; Chung MJ
Pancreas; 2020; 49(10):1348-1354. PubMed ID: 33122524
[TBL] [Abstract][Full Text] [Related]
14. A Quest for Survival: A Review of the Early Biomarkers of Pancreatic Cancer and the Most Effective Approaches at Present.
Bestari MB; Joewono IR; Syam AF
Biomolecules; 2024 Mar; 14(3):. PubMed ID: 38540782
[TBL] [Abstract][Full Text] [Related]
15. CA19‑9 is a significant prognostic factor in stage III gastric cancer patients undergoing radical gastrectomy.
Ma X; Zhou X; Guo J; Feng X; Zhao M; Zhang P; Zhang C; Gong S; Wu N; Zhang Y; Zhang X; Ren Z; Zhang P
BMC Surg; 2024 Jan; 24(1):31. PubMed ID: 38263014
[TBL] [Abstract][Full Text] [Related]
16. In Neoadjuvant FOLFIRINOX Chemotherapy for Pancreatic Ductal Adenocarcinoma, Which Response is the More Reliable Indicator for Prognosis, Radiologic or Biochemical?
Yun WG; Han Y; Cho YJ; Jung HS; Lee M; Kwon W; Jang JY
Ann Surg Oncol; 2024 Feb; 31(2):1336-1346. PubMed ID: 37991581
[TBL] [Abstract][Full Text] [Related]
17. TSTA3 overexpression promotes malignant characteristics in LUSC by regulating LAMP2-mediated autophagy and tumor microenvironment.
Guo Y; Hao Y; Shen L; Du Y; Wang X; Gao L; Feng X; Zhai Y; Liu Z; Xu E; Yang Y; Xi Y; Yang B; Zhang L
Cancer Cell Int; 2023 Nov; 23(1):285. PubMed ID: 37986192
[TBL] [Abstract][Full Text] [Related]
18. Biological risk based on preoperative serum CA19-9 and histological grade predicts prognosis and improves accuracy of classification in patients with pancreatic ductal adenocarcinoma.
Chang S; Liu Y; Liang Y; Man Q; Li H; Guo Y; Zhao T
Cancer Rep (Hoboken); 2023 Dec; 6(12):e1911. PubMed ID: 37827990
[TBL] [Abstract][Full Text] [Related]
19. EphA2 Proteolytic Fragment as a Sensitive Diagnostic Biomarker for Very Early-stage Pancreatic Ductal Carcinoma.
Sato S; Nakagawa M; Terashima T; Morinaga S; Miyagi Y; Yoshida E; Yoshimura T; Seiki M; Kaneko S; Ueno M; Yamashita T; Koshikawa N
Cancer Res Commun; 2023 Sep; 3(9):1862-1874. PubMed ID: 37712876
[TBL] [Abstract][Full Text] [Related]
20. CA 19-9 but Not IGF-1/IGFBP-2 Is a Useful Biomarker for Pancreatic Ductal Adenocarcinoma (PDAC) and Chronic Pancreatitis (CP) Differentiation.
Wlodarczyk B; Durko L; Wlodarczyk P; Talar-Wojnarowska R; Malecka-Wojciesko E
J Clin Med; 2023 Jun; 12(12):. PubMed ID: 37373743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
